Minimum reporting guidelines for platelet-rich plasma in veterinary regenerative medicine.

Abstract

Platelet concentrates such as platelet-rich plasma (PRP) are widely used in veterinary regenerative medicine and transfusion therapy. However, the therapeutic efficacy of PRP is highly dependent on its precise characterization, cellular composition, and preparation methods. Without proper standardization, PRP treatments can yield inconsistent results, undermining their clinical utility. A recent study in Veterinary Research Communications underscores the importance of pH measurement as a key quality control parameter for platelet concentrates, including PRP, in veterinary blood banks. Building on these findings and our own recent experience, we propose revised minimum reporting guidelines for the use of PRP in veterinary regenerative medicine. Adherence to minimum reporting guidelines is essential to ensure reproducibility and reduce heterogeneity in PRP therapies. Future research should focus on species-specific protocols and advanced characterization techniques to enhance the therapeutic potential of PRP. By addressing these challenges, PRP can become a cornerstone of regenerative therapies in veterinary medicine, offering safe and effective treatment options for various diseases and disorders.